Acute spontaneous Spinal Cord Infarctions (SCI) are an uncommon cause of myelopathy (5%), but their prognostic is heterogeneous and frequently severe. Positive diagnosis is difficult, one quarter of initial MRIs are normal. Differential diagnosis with other transverse myelopathy causes is a common issue. As in cerebral stroke, there are multiple causes and mechanisms in spontaneous SCI, often difficult to clearly establish. There are also clinical and radiological patterns, sometimes misleading, according to vascular territory and its expanse. Due to its scarcity and heterogeneity, improving knowledge and medical care remains difficult. Medical care is still badly codified in medical literature. Recently, diagnostic criteria have been proposed to better identify SCI, provide earlier care and homogenize future research. External validity and reproduction of these new criteria among acute myelopathies are still to be validated. While there is no established medical treatment in the initial care of spontaneous SCI, some case reports show successful treatment with IV thrombolysis. Given the severe prognosis, conventional treatment of strokes (thrombolysis, anticoagulant and antiplatelet), could be considered on an individual scale, in a specific protocol. A better knowledge of radio-clinical and security factors are necessary to support this approach. In order to respond to these difficulties, a retrospective cohort will allow us to better define epidemiological, clinico-radiological and prognostic features of spontaneous SCI. It lays the foundation of a possible prospective multicentric cohort, necessary for specific therapeutic studies.
Study Type
OBSERVATIONAL
Enrollment
60
Uhmontpellier
Montpellier, France
description of a recent spontaneous SCI cohort
Number of patients hospitalized for spontaneous SCI in the last 10 years in Montpellier and Nîmes University Hospital
Time frame: 10 years
description of a recent spontaneous SCI cohort
description of patients diagnosed with spontaneous SCI
Time frame: 1 day
evaluation of JAMA 2019 diagnostic criteria in spontaneous SCI and other myelopathies
evaluation of JAMA 2019 diagnostic criteria in spontaneous SCI and other myelopathies
Time frame: 1 day
analysis of relevant clinical and radiological criteria for positive diagnosis and prognosis
analysis of relevant clinical and radiological criteria for positive diagnosis and prognosis
Time frame: 1 day
Description of clinico-radiological territories, etiology and physiopathology of spontaneous SCI, including application of fibrocartilaginous embolism criteria 2015
Description of clinico-radiological territories, etiology and physiopathology of spontaneous SCI, including application of fibrocartilaginous embolism criteria 2015
Time frame: 1 day
Retrospective evaluation of the potential candidates for IV thrombolysis
Retrospective evaluation of the potential candidates for IV thrombolysis
Time frame: 1 day
Evaluation of relevant criteria in order to create a prospective multicentric cohort of spontaneous SCI.
Evaluation of relevant criteria in order to create a prospective multicentric cohort of spontaneous SCI.
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.